Compounds and Combinations Thereof for Treating Neurological and Psychiatric Conditions

Mon, 13 Apr 2026 13:40:19 +0000
Intellectual Property

The USPTO published patent application US20260097006A1 by inventor Herriot Tabuteau, filed September 4, 2025, covering compounds and combinations containing dextromethorphan for treating neurological and psychiatric conditions. The application discloses dosage forms and drug delivery systems typically combined with antidepressants such as bupropion. This publication makes the application publicly available for review and potential opposition.